Matarin Capital Management’s Amphastar Pharmaceuticals AMPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-121,359
| Closed | -$2.34M | – | 201 |
|
|
2019
Q4 | $2.34M | Sell |
121,359
-101,825
| -46% | -$1.96M | 0.22% | 154 |
|
|
2019
Q3 | $4.43M | Sell |
223,184
-13,560
| -6% | -$269K | 0.33% | 109 |
|
|
2019
Q2 | $5M | Buy |
236,744
+15,040
| +7% | +$318K | 0.36% | 103 |
|
|
2019
Q1 | $4.53M | Buy |
221,704
+56,666
| +34% | +$1.16M | 0.33% | 109 |
|
|
2018
Q4 | $3.28M | Buy |
165,038
+121,097
| +276% | +$2.41M | 0.27% | 136 |
|
|
2018
Q3 | $845K | Sell |
43,941
-855
| -2% | -$16.5K | 0.05% | 226 |
|
|
2018
Q2 | $684K | Sell |
44,796
-7,621
| -15% | -$116K | 0.05% | 232 |
|
|
2018
Q1 | $983K | Hold |
52,417
| – | – | 0.07% | 205 |
|
|
2017
Q4 | $1.01M | Hold |
52,417
| – | – | 0.08% | 208 |
|
|
2017
Q3 | $937K | Hold |
52,417
| – | – | 0.08% | 201 |
|
|
2017
Q2 | $936K | Hold |
52,417
| – | – | 0.09% | 187 |
|
|
2017
Q1 | $760K | Buy |
+52,417
| New | +$760K | 0.07% | 207 |
|